Management of Insomnia in Cancer Patients
癌症患者失眠的治疗
基本信息
- 批准号:8137044
- 负责人:
- 金额:$ 13.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-26 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAffectAreaAwardBehavior ControlBehavior TherapyBehavioral ResearchBiometryCancer CenterCancer ControlCancer PatientCancer SurvivorChronic DiseaseChronic InsomniaClinicalClinical TrialsClinical Trials DesignCognitive TherapyCommunity Clinical Oncology ProgramControlled Clinical TrialsDataDevelopmentDevelopment PlansDistressDoctor of PhilosophyEquipment and supply inventoriesFatigueFeedbackFemale Breast CarcinomaGeneral PopulationGlucoseGoalsHigh PrevalenceIncidenceInterventionK-Series Research Career ProgramsKnowledgeLinkMalignant NeoplasmsMeasurableMeasuresMedicalMemoryMentorsMetabolicModafinilModelingNeeds AssessmentOutcomePatientsPerformancePharmaceutical PreparationsPilot ProjectsPlacebosPositioning AttributePsychologistPsychopharmacologyQuality of lifeRadiation therapyRandomizedRandomized Clinical TrialsRelative (related person)ReportingResearchResearch PersonnelRoleScheduleSeveritiesSleepSleep DisordersSleep disturbancesSleeplessnessSpecific qualifier valueStimulusSurveysSymptomsTimeTrainingUniversitiesWakefulnessWorkarmbasecancer diagnosiscancer therapycareercareer developmentchemotherapydesigndisturbance in affectexperiencefallsgastrointestinalimmune functionimprovedmalignant breast neoplasmmood regulationprogramsprospectivepublic health relevanceskillssleep regulationstandard care
项目摘要
DESCRIPTION (provided by applicant): Overview and Public Health Relevance: Oxana Palesh, Ph.D., a clinical psychologist, is applying for a career development award to expand her research skills and become an independent investigator in cancer control. Her long-term research objective is to reduce insomnia and insomnia symptoms in cancer patients and cancer survivors, groups with a high prevalence of these problems. In fact, sleep problems were reported by 70% of 330 breast cancer patients in a recent study by Dr. Palesh. Dr. Palesh's Career Development Plan builds upon a strong research background obtained at Stanford and the U of Rochester by enhancing specific measurable knowledge and skills in four areas: 1) cancer treatment and control, 2) the conduct of multi-center trials, 3) insomnia assessment and treatment, and 4) transitioning to an independent research career. Her primary mentor, Gary Morrow, Ph.D., has been a leader in cancer control for 30 years. He will contribute expertise in cancer and side effect management and in clinical trial design and analysis. Dr. Palesh's co-mentors also have outstanding experience in training researchers. Joseph Roscoe, Ph.D., will contribute expertise in behavioral research and cancer. Thomas Roth, Ph.D., an internationally recognized expert, will provide in-depth training in sleep research and treatment of insomnia. They are assisted by an Advisory Board of experts in cancer treatment, insomnia research, psychopharmacology and biostatistics. Research Plan: The proposed RCT, based on well established theoretical principles, expands promising preliminary data showing that both pharmacologic and behavioral interventions can improve insomnia. The two approaches will be compared with standard care in a 4 arm (Drug: yes/no; Behavioral Treatment: yes/no) randomized clinical trial of 60 breast cancer patients receiving chemotherapy. The primary goal is to provide preliminary data and effect size estimates for an R01 application to confirm results. These results will clarify the role of insomnia in the experiences of cancer patients undergoing treatment, inform potential strategies for interventions in these patients, and position Dr. Palesh, in combination with the training provided by this award, to successfully transition to a career as an independent investigator and leader in cancer control science.
描述(由申请人提供):概述和公共卫生相关性:Oxana Palesh 博士是一名临床心理学家,正在申请职业发展奖,以扩展她的研究技能并成为癌症控制领域的独立研究者。她的长期研究目标是减少癌症患者和癌症幸存者(这些问题的患病率较高的群体)的失眠和失眠症状。事实上,Palesh 博士最近的一项研究显示,330 名乳腺癌患者中有 70% 的人存在睡眠问题。 Palesh 博士的职业发展计划建立在斯坦福大学和罗彻斯特大学强大的研究背景之上,通过增强四个领域的具体可衡量知识和技能:1) 癌症治疗和控制,2) 进行多中心试验,3)失眠评估和治疗,以及 4) 过渡到独立研究生涯。她的主要导师 Gary Morrow 博士 30 年来一直是癌症控制领域的领导者。他将贡献癌症和副作用管理以及临床试验设计和分析方面的专业知识。帕莱什博士的共同导师在培训研究人员方面也拥有杰出的经验。 Joseph Roscoe 博士将贡献行为研究和癌症方面的专业知识。国际公认的专家Thomas Roth博士将提供睡眠研究和失眠治疗方面的深入培训。他们得到癌症治疗、失眠研究、精神药理学和生物统计学专家咨询委员会的协助。研究计划:拟议的随机对照试验基于既定的理论原理,扩展了有希望的初步数据,表明药物和行为干预都可以改善失眠。这两种方法将在一项 4 臂(药物:是/否;行为治疗:是/否)随机临床试验中对 60 名接受化疗的乳腺癌患者进行比较。主要目标是为 R01 应用提供初步数据和效应大小估计以确认结果。这些结果将阐明失眠在接受治疗的癌症患者经历中的作用,为这些患者的潜在干预策略提供信息,并使 Palesh 博士结合该奖项提供的培训,成功过渡到作为失眠症患者的职业生涯。癌症控制科学的独立研究者和领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oxana G Palesh其他文献
Oxana G Palesh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oxana G Palesh', 18)}}的其他基金
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)
乳腺癌幸存者的超长期神经认知结果(ProbC2)
- 批准号:
10558447 - 财政年份:2022
- 资助金额:
$ 13.58万 - 项目类别:
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)
乳腺癌幸存者的超长期神经认知结果(ProbC2)
- 批准号:
10643569 - 财政年份:2022
- 资助金额:
$ 13.58万 - 项目类别:
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia
短期行为疗法治疗癌症相关失眠的多中心随机对照试验
- 批准号:
10642316 - 财政年份:2022
- 资助金额:
$ 13.58万 - 项目类别:
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia
短期行为疗法治疗癌症相关失眠的多中心随机对照试验
- 批准号:
10591478 - 财政年份:2022
- 资助金额:
$ 13.58万 - 项目类别:
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia
短期行为疗法治疗癌症相关失眠的多中心随机对照试验
- 批准号:
9916223 - 财政年份:2020
- 资助金额:
$ 13.58万 - 项目类别:
Efficacy of Brief Behavioral Therapy for Cancer-Related Insomnia in Reducing Headache Burden: Exploring Patient Phenotypes and Predictors of Response
简短行为疗法治疗癌症相关失眠在减轻头痛负担方面的功效:探索患者表型和反应预测因子
- 批准号:
10302033 - 财政年份:2020
- 资助金额:
$ 13.58万 - 项目类别:
Brief Behavioral Intervention for Insomnia During Chemotherapy
化疗期间失眠的简短行为干预
- 批准号:
8720244 - 财政年份:2014
- 资助金额:
$ 13.58万 - 项目类别:
Brief Behavioral Intervention for Insomnia During Chemotherapy
化疗期间失眠的简短行为干预
- 批准号:
9276643 - 财政年份:2014
- 资助金额:
$ 13.58万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Impacts of Acute Ambient Air Pollution Exposure on Women's Reproductive Health: Identifying Mechanisms and Susceptible Reproductive Processes Across the Menstrual Cycle and Early Pregnancy
急性环境空气污染暴露对女性生殖健康的影响:确定月经周期和怀孕早期的机制和易受影响的生殖过程
- 批准号:
10645818 - 财政年份:2023
- 资助金额:
$ 13.58万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 13.58万 - 项目类别:
Intermittent Hypoxia Initiated Motor Plasticity in Individuals with Multiple Sclerosis
间歇性缺氧引发多发性硬化症患者的运动可塑性
- 批准号:
10593412 - 财政年份:2023
- 资助金额:
$ 13.58万 - 项目类别:
Processivity and Catalytic Mechanism of Aldosterone Synthase
醛固酮合酶的持续合成能力和催化机制
- 批准号:
10600520 - 财政年份:2023
- 资助金额:
$ 13.58万 - 项目类别:
Perinatal Affective Symptoms, Neuroactive Steroids, and GABA Receptor Plasticity in Women of Color
有色人种女性的围产期情感症状、神经活性类固醇和 GABA 受体可塑性
- 批准号:
10572847 - 财政年份:2023
- 资助金额:
$ 13.58万 - 项目类别: